第1回
Display of Difficult Targets
-難標的表示シンポジウム-
2月19日〜20日
結晶構造が入手可能になったことで、イオンチャネルやGタンパク質共役受容体(CPCR)を含む膜タンパク質の理解が大きく進みつつあります。また、膜タンパク質と一緒に使用できるようファージや酵母を適応させる研究も進んでいます。このシンポジウムは、タンパク質の選択、共結晶化、アゴニスト結合と活性化、発現と精製のための手法などに焦点を絞り込んだもので、これらの手法は、難標的に対応する薬剤の開発に役立つと期待されています。
Who Should Attend: VPs, Directors, Managers, CEOs, CSOs, Professors and Scientists from Large Pharma, Biotechs and Academia working in fields such as Antibody Engineering, R&D, Lead Discovery, Diagnostics, Therapeutics, Biologics and Chemistry.
Topics will include, but are not limited to:
- Insights from crystal structures of membrane proteins
- Antibody selection against membrane proteins
- Expression and purification of multi-pass proteins
- Locking GPCR conformation with ligands or antibodies
- Strategies for drug development
- Evolution of ligands to membrane proteins
The deadline for submission is July 29, 2011.
All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
